1,961 results match your criteria Lymphoma Diffuse Mixed


Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma.

Ecancermedicalscience 2018 13;12:887. Epub 2018 Dec 13.

Department of Radiation Oncology, Hospital de Braga, Braga, Portugal.

Introduction And Aims: Splenic marginal zone lymphoma, an uncommon subtype of non-Hodgkin lymphoma (NHL), is usually present with symptomatic splenomegaly. Although splenectomy has long been considered the first-line therapy in symptomatic or cytopenic patients, it can lead to significant morbidity and mortality. Splenic irradiation is an option for patients who have a poor response to systemic therapy and/or are not surgical candidates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2018.887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351061PMC
December 2018

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.

Haematologica 2019 Feb 21. Epub 2019 Feb 21.

University of Virginia School of Medicine, Charlottesville, Virginia, USA.

CD20 monoclonal antibody therapies have significantly improved the outlook for patients with B-cell malignancies. However many patients acquire resistance, demonstrating the need for new and improved drugs. We previously demonstrated that the natural process of antibody hexamer formation on targeted cells allows for optimal induction of complement-dependent cytotoxicity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.207266DOI Listing
February 2019

Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.

Support Care Cancer 2019 Feb 14. Epub 2019 Feb 14.

Department of Endocrinology, Hospital of Southwest Jutland, Esbjerg, Jutland, Denmark.

Purpose: Chemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04666-8DOI Listing
February 2019
2 Reads

Leptin rs2167270 G > A (G19A) polymorphism may decrease the risk of cancer: A case-control study and meta-analysis involving 19 989 subjects.

J Cell Biochem 2019 Jan 29. Epub 2019 Jan 29.

Department of Gastroenterology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.

Accumulating evidence has suggested that leptin (LEP) is very important for the development of cancer. Recently, a number of case-control studies about the relationship of the rs2167270 G > A (G19A) variants in the LEP gene with the risk of cancer have yielded inconsistent results. In this study, we have carried out a case-control study [1063 esophagogastric junction adenocarcinoma (EGJA) cases and 1677 controls] in a Chinese population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.28378DOI Listing
January 2019
1 Read

Feline Lymphoma and a High Correlation with Feline Leukaemia Virus Infection in Brazil.

J Comp Pathol 2019 Jan 29;166:20-28. Epub 2018 Nov 29.

Laboratory of Animal Pathology, Agroveterinary Sciences Center, Brazil. Electronic address:

Lymphoma is the most important haemopoietic tumour in cats and has been associated with feline leukaemia virus (FeLV) infection. In Brazil, no studies have established a correlation between FeLV infection and lymphoma. The aim of this study was to characterize lymphomas arising in cats in Brazil anatomically and microscopically, and to correlate these data with FeLV infection as determined by immunohistochemistry for the FeLV gp70 antigen. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcpa.2018.10.171DOI Listing
January 2019
1 Read

Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP.

Cancer Chemother Pharmacol 2019 Jan 28. Epub 2019 Jan 28.

Radio-Pharmacology Department, Institut Curie, 35 Rue Dailly, 92210, Saint Cloud, France.

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in elderly patients, and R-CHOP chemotherapy is the standard treatment protocol for DLBCL. Elderly patients (often defined as 75 years of age) are treated with anticancer drugs with precaution; however, the pharmacokinetics and pharmacodynamics (PK and PD) of these agents have not been thoroughly investigated in this population. In this study, we investigated the PK of cyclophosphamide (CP) and doxorubicin (DOXO) in elderly patients in order to verify if there is an influence of age on the PK of these anticancer drugs. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-019-03775-9
Publisher Site
http://dx.doi.org/10.1007/s00280-019-03775-9DOI Listing
January 2019
4 Reads

HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?

J Thorac Dis 2018 Nov;10(11):6040-6049

Department of Radiology, Shanghai Oriental Hospital Affiliated Tongji University, Shanghai 200120, China.

Background: Primary pulmonary lymphoma (PPL) mainly comprises mucosa-associated lymphoid tissue (MALT) lymphoma as well as other subtypes of lymphoma. Different phenotypes of PPL demonstrate various high-resolution computed tomography (HRCT) features. We aimed to evaluate the value of HRCT in the diagnosis and differential diagnosis of PPL, especially between MALT lymphoma and non-MALT lymphoma and the correlation between CT and pathological features. Read More

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/24876/19082
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.10.63DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297407PMC
November 2018
5 Reads

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone.

Case Rep Pathol 2018 26;2018:4160925. Epub 2018 Nov 26.

Professor, Department of Orthopaedics, Zucker/Hofstra North Shore Long Island Jewish, Northwell Health Medical Center, New Hyde Park, NY, USA.

Primary lymphoma of bone (PLB) confined to the epiphysis has only been described in four other patients. Due to the rarity of this entity, diagnosis has often been delayed, leading to mismanagement with adverse clinical consequences. We report a fifth case of primary epiphyseal lymphoma of bone located in the left distal medial femoral epiphysis of a 13-year-old boy. Read More

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/cripa/2018/4160925/
Publisher Site
http://dx.doi.org/10.1155/2018/4160925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287168PMC
November 2018
7 Reads

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma

Asian Pac J Cancer Prev 2018 Dec 25;19(12):3463-3466. Epub 2018 Dec 25.

Department of Pathology, Bilawal Medical College, Liaquat University of Medical and Health Sciences, Pakistan. Email:

Background: B-cell malignancies including Precursor B-cell lymphoblastic lymphoma/leukemia and Hodgkin Lymphoma show a wide spectrum of B-cell differentiation from early stage B-cell precursors to mature B-cells ending in terminal differentiation to plasma cells. Pan-B-cell antigens routinely used for the diagnosis of B-cell lymphoma, include CD19, CD20, CD22 and CD79a.PAX-5 protein, also known as B-cell-specific activation protein is a B-cell-specific transcription factor; essential for commitment and functional maintenance used in the diagnosis of B cell Hodgkin and non-Hodgkin lymphoma. Read More

View Article

Download full-text PDF

Source
http://journal.waocp.org/article_80032.html
Publisher Site
http://dx.doi.org/10.31557/APJCP.2018.19.12.3463DOI Listing
December 2018
7 Reads

Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.

Br J Clin Pharmacol 2019 Mar 21;85(3):590-600. Epub 2019 Jan 21.

Pfizer Oncology, Collegeville, PA, USA.

Aim: The aim of this study was to characterize the effect of inotuzumab ozogamicin on QT interval in patients with B-cell malignancies.

Methods: Data were pooled from three clinical studies including 250 patients (n = 2743) who received inotuzumab ozogamicin monotherapy. Patients with relapsed/refractory acute lymphoblastic leukaemia (NCT01564784 and NCT01363297) received 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13832DOI Listing
March 2019
5 Reads

Pathological Characterization of Lymphoma with Pulmonary Involvement in Cats.

J Comp Pathol 2018 Nov 19;165:6-12. Epub 2018 Oct 19.

Setor de Patologia Veterinária, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Studies evaluating histological patterns of lung infiltration by lymphoma in cats are lacking. We evaluated retrospectively the histological patterns of 125 necropsy cases of feline lymphoma collected over a 12-year period. Of the 125 cases, 16 showed lung infiltration (12. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcpa.2018.09.007DOI Listing
November 2018
1 Read

Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.

Br J Haematol 2019 Feb 22;184(4):547-557. Epub 2018 Nov 22.

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Allogeneic haematopoietic stem cell transplant (allo-HSCT) offers potentially curative therapy for patients with relapsed/refractory lymphoid malignancies. Reduced-intensity conditioning (RIC) with Alemtuzumab reduces transplant-related mortality and graft-versus-host disease (GvHD), but may be associated with increased risk of relapse. With the aim of studying the effect of GVHD and donor lymphocyte infusions (DLI) on relapse, we performed a retrospective study of 288 patients (57% non-Hodgkin lymphoma, 24% Hodgkin lymphoma and 19% chronic lymphocytic leukaemia; 58% were relapsed/refractory) who underwent RIC-Alemtuzumab-HSCT between 2000 and 2012. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15685DOI Listing
February 2019
9 Reads

Periportal hepatic involvement of non-Hodgkin lymphoma: a rare case report with magnetic resonance imaging findings.

Authors:
Mehmet Beyazal

J Int Med Res 2019 Feb 22;47(2):986-991. Epub 2018 Nov 22.

Department of Radiology, Recep Tayyip Erdoğan University, School of Medicine, Rize, Turkey.

Lymphoma with hepatic involvement can present with three morphological patterns: diffuse infiltrative, nodular, and mixed infiltrative-nodular. However, lymphoma with periportal infiltrative hepatic involvement is rare. There have been a few reports of cases with this type of hepatic involvement including ultrasound or computed tomography (CT) findings. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060518810869DOI Listing
February 2019
7 Reads

Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.

Clin Exp Med 2019 Feb 14;19(1):1-21. Epub 2018 Nov 14.

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari "Aldo Moro", Polyclinic, Piazza G. Cesare, 11, 70124, Bari, Italy.

Cryoglobulins are circulating immunoglobulins that reversibly precipitate at temperatures below 37 °C. Type-II cryoglobulins consist of monoclonal IgM/polyclonal IgG immune complexes (ICs), whereas in type-III cryoglobulins both IgM and IgG are polyclonal. The clinical condition resulting from the presence of cryoglobulins in the blood is called mixed cryoglobulinemia (MC), which can be asymptomatic or manifest as cryoglobulinemic vasculitis (CV). Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10238-018-0536-z
Publisher Site
http://dx.doi.org/10.1007/s10238-018-0536-zDOI Listing
February 2019
12 Reads

Primary hypoaldosteronism in a dog with pituitary and adrenal T-cell lymphoma.

J Small Anim Pract 2018 Nov 3. Epub 2018 Nov 3.

Department of Internal Medicine, Ecole nationale vétérinaire d'Alfort, Paris, F-94700, France.

A 7-year-old mixed breed dog was presented with a 2-week history of vomiting, diarrhoea, weakness and loss of appetite. Initial laboratory tests revealed hyponatraemia and hyperkalaemia consistent with hypoadrenocorticism. Basal plasma cortisol and adrenocorticotropic hormone concentrations were not suggestive of primary hypoadrenocorticism but the aldosterone concentration was undetectable. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jsap.12955DOI Listing
November 2018
3 Reads

Silicone-Induced Granuloma of Breast Implant Capsule (SIGBIC): Histopathology and Radiological Correlation.

J Immunol Res 2018 20;2018:6784971. Epub 2018 Sep 20.

Brazilian Cancer Control Institute, Brazil.

Currently, attention has been given to complications related to breast implants, especially due to the presence of anaplastic large cell lymphoma (ALCL) related to silicone implants. Many manuscripts attempt to associate silicone presence with clinical complaints reported by patients, while others try to demonstrate the mechanisms of silicone bleeding by permeability loss of breast implant surfaces. There also are reports of foreign body type reactions from implant fibrous capsule to silicone corpuscles. Read More

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/jir/2018/6784971/
Publisher Site
http://dx.doi.org/10.1155/2018/6784971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171257PMC
December 2018
6 Reads

Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men.

Cancer Causes Control 2018 Nov 12;29(11):1131-1142. Epub 2018 Oct 12.

Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Center for Life Science 1010, 450 Brookline Avenue, Boston, MA, 02215, USA.

Immunological parameters that influence susceptibility to virus-associated cancers in HIV-seronegative individuals are unclear. We conducted a case-control cohort study of immunological parameters associated with development of incident virus-associated cancers among 532 HIV-seronegative men who have sex with men (MSM) enrolled in the Multicenter AIDS Cohort Study (MACS) with median (IQR) 21 (8-26) years of follow-up. Thirty-two incident virus-associated cancers (anal cancer, non-Hodgkin lymphoma, liver cancer, other cancers with etiologies linked to human papillomavirus, Epstein-Barr virus, hepatitis B virus, or human herpesvirus-8) were identified among 3,408 HIV-seronegative men in the MACS during 1984-2010. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-018-1090-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245112PMC
November 2018
3 Reads

Epidemiologic characteristics of malignant lymphoma in Hubei, China: A single-center 5-year retrospective study.

Medicine (Baltimore) 2018 Aug;97(35):e12120

Cancer Center.

Distribution of different malignant lymphoma subtypes varies substantially in different geographic regions, even in different districts in China.In order to estimate the epidemiologic characteristics of malignant lymphoma in Hubei, China, we retrospectively analyzed a total number of 2027 newly diagnosed cases from April 2009 to April 2014 in a single institution according to the 2008 WHO classification.The median diagnosis age of all these lymphoma patients was 53 (1-99) years, and the median ages for non-(NHL) and Hodgkin lymphoma (HL) were 54 (1-99) years and 38 (5-84) years, respectively. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201808310-0007
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000012120DOI Listing
August 2018
13 Reads
5.723 Impact Factor

A Comparison of the Histopathologic Growth Patterns Between Non-Merkel Cell Small Round Blue Cell Tumors and Merkel Cell Carcinoma.

Am J Dermatopathol 2018 Nov;40(11):815-818

Department of Dermatology, Medical University of South Carolina, Charleston, SC.

Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous malignancy that shares cytologic, histopathologic, and immunohistochemical features with other small round blue cell (SRBC) tumors. Although the trabecular pattern is anecdotally associated with MCC, objective data are lacking.

Methods: This was a retrospective institutional review board-approved observational study conducted on microscopic images of 79 MCCs and 74 other SRBC tumors (desmoplastic small round cell tumor, primitive neuroectodermal tumor, neuroblastoma, embryonal rhabdomyosarcoma, alveolar rhabdomyosarcoma, synovial sarcoma, carcinoid, metastatic small cell lung cancer, non-Hodgkin small cell lymphoma, retinoblastoma, medulloblastoma, nephroblastoma, small cell osteosarcoma, and round cell liposarcoma). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000001232DOI Listing
November 2018
9 Reads
1.430 Impact Factor

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Oncotarget 2018 Jul 3;9(51):29753-29771. Epub 2018 Jul 3.

Department of Oncology, University of Turin, Torino, Italy.

In order to investigate the role of microRNAs in the pathogenesis of different B-cell lymhoma subtypes, we have applied an array-based assay to a series of 76 mixed non-Hodgkin B-cell lymphomas, including Burkitt's lymphoma (BL), diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, mantle cell lymphoma (MCL) and follicular lymphoma. Lymphomas clustered according to histological subtypes, driven by two miRNA clusters (the miR-29 family and the miR-17-92 cluster). Since the two miRNA clusters are known to be MYC-regulated, we investigated whether this would be supported in MYC-driven experimental models, and found that this signature separated BL cell lines and a -translocated MCL cell lines from normal germinal center B-cells and other B-cell populations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049865PMC
July 2018
6 Reads

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma.

Cancer Res Treat 2018 Jul 10. Epub 2018 Jul 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Purpose: Duodenal-type follicular lymphoma (FL) is a rare variant of FL. There is still no consensus on the initial treatment, and clinical features including endoscopic findings are not familiar to most physicians. The objective of this study was to evaluate the outcome of patients who were initially treated with radiation therapy for duodenal-type FL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.190DOI Listing
July 2018
4 Reads

Spectrum of lymphoma in Bahrain. A retrospective analysis according to the World Health Organization classification.

Saudi Med J 2018 Jul;39(7):736-739

Anatomical Pathology Specialist, Department of Pathology, Salmaniya Medical Center, Manama, Kingdom of Bahrain. E-mail.

Objectives: To determine the spectrum of various types of lymphoma in Bahrain according to the latest World Health Organization classification criteria.  Methods: A retrospective review was conducted for all new lymphoma cases diagnosed at Salmaniya Medical Complex, Manama, Bahrain during the period from January 2010 to December 2015.  Results: Two hundred and twenty-one new cases of lymphoma in Bahraini patients were diagnosed in the study period. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15537/smj.2018.7.23065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146247PMC
July 2018
28 Reads
0.554 Impact Factor

F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma.

Indian J Nucl Med 2018 Jul-Sep;33(3):183-189

Department of Radiology, National Cancer Institute, Cairo University, Giza, Egypt.

Aim And Objectives: The aim of this study is to assess the added value of hybrid fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in the evaluation of extranodal involvement in patients with lymphoma in comparison to contrast-enhanced CT (CECT).

Patients And Methods: All patients had lymphoma, proved by histopathological and immunophenotyping examinations. They underwent CECT and F-18 FDG PET-CT studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijnm.IJNM_47_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011550PMC
July 2018
22 Reads

Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.

Leukemia 2019 Jan 26;33(1):132-147. Epub 2018 Jun 26.

Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Cancer cells subvert host immune surveillance by altering immune checkpoint (IC) proteins. Some Epstein-Barr virus (EBV)-associated tumors have higher Programmed Cell Death Ligand, PD-L1 expression. However, it is not known how EBV alters ICs in the context of its preferred host, the B lymphocyte and in derived lymphomas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0178-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327052PMC
January 2019
17 Reads

Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity.

Leuk Res 2018 Aug 17;71:1-5. Epub 2018 Jun 17.

Departments of Hematology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address:

Patients with inflammatory bowel disease (IBD) on immunosuppression are at risk of developing lymphoma, particularly primary gastrointestinal (GI) tract non-Hodgkin lymphoma. Primary GI Hodgkin lymphoma (HL) in this setting, however, is rare and poorly defined. Here we review the available literature and also report a patient with Crohn's disease (CD) who developed GI HL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.06.008DOI Listing
August 2018
10 Reads

Reappraisal of nodal Epstein-Barr Virus-negative cytotoxic T-cell lymphoma: Identification of indolent CD5 diseases.

Cancer Sci 2018 Aug 26;109(8):2599-2610. Epub 2018 Jun 26.

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Nodal cytotoxic molecule (CM)-positive peripheral T-cell lymphoma (CTL) has recently been recognized as a clinicopathologically distinct disease. To further characterize this disease, here we compared 58 patients with Epstein-Barr virus (EBV)-negative CTL to 48 patients with EBV-positive CTL. The two groups did not differ in histopathology, T-cell receptor (TCR) expression or rearrangement incidences, or survival curves. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113510PMC
August 2018
5 Reads

Hemophagocytic Lymphohistiocytosis Secondary to Unknown Underlying Hodgkin Lymphoma Presenting with a Cholestatic Pattern of Liver Injury.

Case Rep Gastroenterol 2018 Jan-Apr;12(1):99-108. Epub 2018 Apr 24.

University of Texas Medical Branch, Galveston, Texas, USA.

Hemophagocytic lymphohistiocytosis (HLH) is an uncommon disease that often presents with nonspecific findings. A high index of suspicion is necessary to make a prompt diagnosis and prevent fatal disease. A 45-year-old man presented with fever, hypotension, abdominal pain, nausea, and vomiting. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/486190
Publisher Site
http://dx.doi.org/10.1159/000486190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968292PMC
April 2018
9 Reads

Cryoglobulinemic Glomerulonephritis Associated With Nodal and Renal Infiltration by T-Cell Lymphoma of T-Follicular Helper Phenotype: A Case Report.

Am J Kidney Dis 2018 Oct 18;72(4):606-611. Epub 2018 May 18.

Department of Renal Medicine, Westmead Hospital, Sydney, NSW, Australia.

We present a unique case of cryoglobulinemic glomerulonephritis associated with nodal and renal infiltration by T-cell lymphoma of T-follicular helper phenotype. The patient presented with transient neurologic symptoms, severe nephritic syndrome with nephrotic-range proteinuria, and acute kidney injury. He had elevated double-stranded DNA levels, low complement levels, detectable cryoglobulin, and detectable immunoglobulin M (IgM) paraprotein. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2018.03.024DOI Listing
October 2018
15 Reads

Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.

J Nucl Med 2019 Jan 18;60(1):60-64. Epub 2018 May 18.

Division of Hematology and Medical Oncology, Department of Internal Medicine II, Universitätsklinikum Würzburg, Würzburg, Germany; and.

We have recently reported on our experience with C-X-C-motif chemokine receptor 4 (CXCR4)-directed radioligand therapy (RLT) in multiple myeloma and acute leukemia. Six patients with heavily pretreated relapsed diffuse large B-cell lymphoma (3 men, 3 women; aged, 54 ± 8 y) underwent CXCR4-directed RLT in combination with conditioning chemotherapy and allogeneic stem cell transplantation. In 2 patients, radioimmunotherapy targeting CD20 or CD66 was added to enhance antilymphoma activity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.118.210997DOI Listing
January 2019
21 Reads

Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.

Diseases 2018 May 3;6(2). Epub 2018 May 3.

Department of Clinical and Surgical Sciences, University of Trieste, 34121 Trieste, Italy.

Introduction: The clinical and therapeutic management of mixed cryoglobulinemia (MC) remains a subject of controversy. In addition, most studies have not recorded the long-term follow-up and the outcome of these cases.

Material And Methods: We enrolled 246 patients affected by MC who were consecutively admitted to our Department from January 1993 to February 2013. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diseases6020035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023473PMC
May 2018
9 Reads

Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

J Clin Exp Hepatol 2018 Mar 7;8(1):81-94. Epub 2017 Dec 7.

Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania, 2 Dulles, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Hepatitis C Virus (HCV)-related Mixed Cryoglobulinemia (MC) is a unique condition with complex pathogenesis that involves HCV antigen-driven B-lymphocyte clonal proliferation and mutagenesis. Clinical spectrum of MC ranges from asymptomatic state to clinically-apparent vasculitis involving multiple organs. In the era of Direct-Acting Antiviral (DAA) therapy, patients with HCV-related MC achieve high rates of viral clearance that is commonly accompanied by an improvement in clinical symptoms as well as immunological profiles. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jceh.2017.11.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938331PMC
March 2018
3 Reads

Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma.

Pediatr Transplant 2018 08 2;22(5):e13210. Epub 2018 May 2.

Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA.

Relapsed ALK-positive ALCL often is responsive to CRZ monotherapy. The subsequent role of allogeneic HCT after achieving second remission is poorly understood. We report 6 children who underwent allogeneic HCT for relapsed ALCL after CRZ. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.13210DOI Listing
August 2018
5 Reads

Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.

Int J Cancer 2018 09 26;143(6):1335-1347. Epub 2018 Apr 26.

National Taiwan University, Taipei, Taiwan.

Recent prospective studies have shown that dysregulation of the immune system may precede the development of B-cell lymphomas (BCL) in immunocompetent individuals. However, to date, the studies were restricted to a few immune markers, which were considered separately. Using a nested case-control study within two European prospective cohorts, we measured plasma levels of 28 immune markers in samples collected a median of 6 years before diagnosis (range 2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100111PMC
September 2018
17 Reads

Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution.

Ann Diagn Pathol 2018 Jun 12;34:60-65. Epub 2017 May 12.

Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address:

To explore the distribution of lymphoid neoplasms in Northwest China, the clinical and pathological data of lymphoma patients from 2006 to 2014 were analyzed according to the WHO classification in Xijing Hospital. Of the 3244 cases, mature B-cell neoplasms occupied 60.7%, while mature T/NK-cell neoplasms and Hodgkin's lymphomas (HL) occupied 26. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2017.05.005DOI Listing
June 2018
7 Reads

Primary lymphomatoid granulomatosis in the central nervous system: A report of three cases.

Neuropathology 2018 Apr 10. Epub 2018 Apr 10.

Department of Pathology, Seoul National University, College of Medicine, Seoul, Korea.

Lymphomatoid granulomatosis (LYG) is a rare lymphoproliferative disorder characterized by infiltration of Epstein-Barr virus (EBV)-positive large atypical B-cells in an angiocentric fashion in a mixed inflammatory background. The histologic spectrum of LYG ranges from reactive proliferation to diffuse large B-cell lymphoma according to the number of EBV+ B-cells. It is known that virtually all patients have pulmonary involvement, whereas primary LYG of the other organs has been rarely reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/neup.12467DOI Listing
April 2018
14 Reads

Giant solitary primary intracranial lymphoma masquerading as meningioma: a case and review of literature.

Pan Afr Med J 2017 1;28:196. Epub 2017 Nov 1.

Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guo Xue Xiang Road, Chengdu, 610041, PR, China.

Non-Hodgkin's lymphomas (NHL) with intracranial origin are very rare and constitutes about 1-2% of primary central nervous system lymphomas (PCNSL). Diffuse large B cell lymphoma (DLBCL) is the most common subtype of NHL and mostly seen in immunocompromised patients. Therefore, the occurrence of giant solitary DLBCL in an immunocompetent patient is puzzling. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2017.28.196.13996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878841PMC
May 2018
11 Reads

Aggressive Angioimmunoblastic T Cell Lymphomas (AITL) with Soft Tissue Extranodal Mass Varied Histopathological Patterns with Peripheral Blood, Bone Marrow, and Splenic Involvement and Review of Literature.

Indian J Surg Oncol 2018 Mar 18;9(1):11-14. Epub 2017 May 18.

CHEC Kolkata, Kolkata, India.

Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell non-Hodgkin lymphoma with an aggressive fatal course and it has varied clinical presentation with an uncommon presentation when they present as soft tissue masses or when there is spill in the peripheral blood or there are composite lymphomas that are rare presentations. Common presentations include lymphadenopathy, fever and systemic symptoms, hemolytic anemias, skin rashes, and rheumatoid arthritis. The classical histopathology is absence of follicles in lymph nodes with presence of high endothelial venules and the tumor cells of small to medium-sized lymphocytes with pale cytoplasm mixed with reactive T cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13193-017-0657-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856684PMC
March 2018
13 Reads

Use of complementary and alternative medicine by lymphoma survivors in South Korea.

Eur J Oncol Nurs 2018 Apr 20;33:91-96. Epub 2018 Feb 20.

Division of Hematology-Oncology, Inha University Hospital and College of Medicine, Incheon, South Korea.

Purpose: We aimed to examine the experience of complementary and alternative medicine (CAM) use and its association with health-related quality of life (HRQOL) in lymphoma survivors in South Korea.

Methods: The participants were 869 lymphoma survivors from three hospitals in South Korea, all diagnosed with lymphoma at least 24 months prior to participation. Self-reported questionnaires were used to assess CAM use. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2018.01.012DOI Listing
April 2018
7 Reads

Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.

Exp Mol Pathol 2018 04 1;104(2):130-133. Epub 2018 Mar 1.

Department of Pathology, Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90502, USA.

Background: Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by the Philadelphia (Ph) chromosome generated by the reciprocal translocation t(9,22)(q34;q11). The natural progression of the disease follows a biphasic or triphasic course. Most cases of CML are diagnosed in the chronic phase. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144800183009
Publisher Site
http://dx.doi.org/10.1016/j.yexmp.2018.02.005DOI Listing
April 2018
18 Reads

Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study.

Clin Exp Rheumatol 2018 Mar-Apr;36 Suppl 111(2):107-114. Epub 2018 Feb 13.

Department Clinical and Surgical Sciences, University of Trieste, Italy.

Objectives: To investigate the long-term effects and safety of new direct anti-viral agents (DAAs) in patients with hepatitis C virus (HCV)-related mixed cryoglobulinaemia (MC) without renal involvement.

Methods: The study enrolled 22 consecutive patients, 19 received sofosbuvir-based regimen and three patients received other DAAs, individually tailored according to latest guidelines. As of December 2016, the median length of follow-up was 17 months (range 13-21). Read More

View Article

Download full-text PDF

Source
July 2018
12 Reads

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.

Am J Surg Pathol 2018 05;42(5):646-655

Laboratory of Medicine, Pathology Unit, Mayo Clinic, Scottsdale, AZ.

The diagnostic criteria of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) are not well defined, and DIPNECH can be mistaken for carcinoids associated with neuroendocrine cell hyperplasia (NECH). In this study, we compared clinical, radiologic, histologic, immunohistochemical, and molecular features of DIPNECH and isolated carcinoids with/without NECH. The study population included 151 cases (77 female patients and 74 male patients), 19 with DIPNECH and 132 with carcinoids with/without NECH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001033DOI Listing
May 2018
9 Reads
5.145 Impact Factor

Meningeal marginal zone B-cell lymphoma: The meningioma trap.

Eur Ann Otorhinolaryngol Head Neck Dis 2018 Apr 10;135(2):131-132. Epub 2018 Jan 10.

Service d'ORL, chirurgie cervico-faciale, hôpital Européen-Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France.

Objective: To report a case of marginal zone MALT lymphoma of the temporal dura mater, initially mistaken for temporal meningioma.

Case Report: A 60-year-old immunocompetent woman, followed for more than 10 years for temporal meningioma causing vertigo and mixed hearing loss, presented with cervical lymphadenopathy, revealing marked progression of an intracranial lesion, leading to a diagnosis of marginal zone MALT lymphoma based on histological examination of a cervical lymph node. Treatment with 6 cycles of rituximab and bendamustine allowed complete remission of cervical lymph node and intracranial lesions, confirming the diagnosis of temporal dural mater lymphoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anorl.2017.12.002DOI Listing
April 2018
3 Reads

Hypopigmented mycosis fungoides: a 20-case retrospective series.

Int J Dermatol 2018 Mar 10;57(3):306-312. Epub 2018 Jan 10.

Sector of Dermatology, Post-Graduation Course in Dermatology and Post Graduation Program in Medical Clinics, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Background: Hypopigmented mycosis fungoides (hMF) is a rare subtype of mycosis fungoides. The aim of this study was to identify the clinical-epidemiological profile of our patient group and also to provide additional information about treatment responses and prognosis.

Methods: This is a cross-sectional retrospective observational study, with exploratory analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13855DOI Listing
March 2018
4 Reads

Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.

Vet Comp Oncol 2018 Jun 22;16(2):276-287. Epub 2017 Dec 22.

Queen Mother Hospital for Animals, Royal Veterinary College, University of London, North Mymms, UK.

Canine lymphoma is a heterogeneous group of diseases and many previous studies have evaluated the response of a mixed population of lymphoma cases to one specific treatment protocol. The aim of this retrospective study was to describe the outcome and prognostic factors in 42 cases of multicentric centroblastic diffuse large B-cell lymphoma treated with either a COP-type (35%) or CHOP-type (64%) induction chemotherapy. The objective response rate to induction therapy was 94%; entire dogs had a greater rate of complete vs partial remissions than neutered dogs (P = . Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vco.12378DOI Listing
June 2018
2 Reads

The First Case of Non-leukemic Sarcoma Composed of Mixed-phenotype Acute Leukemia, B/myeloid, Not Otherwise Specified.

Intern Med 2018 Apr 21;57(8):1155-1158. Epub 2017 Dec 21.

Hematology, Graduate School of Medicine, Osaka City University, Japan.

Isolated sarcoma with features of mixed-phenotype acute leukemia (MPAL) is an extremely rare disease and it can be easily misdiagnosed as lymphoma or other malignancies. We herein report the case of a 61-year-old woman with non-leukemic sarcoma of the right pleura, pretracheal lymph node, and supraclavicular lymph node with features of MPAL, B/myeloid, not otherwise specified, which was first misdiagnosed as diffuse large B cell lymphoma. After performing a detailed re-examination of the biopsy specimens, few scattered eosinophilic myelocytes allowed us to reach a correct diagnosis of MPAL and the patient was thereafter successfully treated by intensified chemotherapy followed by cord blood transplantation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.9144-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938510PMC
April 2018
10 Reads

Comparison of sonographic characteristics of primary thyroid lymphoma and anaplastic thyroid carcinoma.

J Thorac Dis 2017 Nov;9(11):4774-4784

Department of Ultrasound, Fatou Community Health Center, Beijing 100023, China.

Background: Although primary thyroid lymphoma (PTL) and anaplastic thyroid carcinoma (ATC) both account for a rare portion of the morbidity of all thyroid malignancies, the therapeutic methods and prognosis for these two diseases are different. The purpose of this study was to investigate the sonographic characteristics of PTL and ATC and to compare the sonographic findings of PTL and ATC.

Methods: The study included 42 patients with histopathologically proven PTL (n=27) and ATC (n=15). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.09.48DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720985PMC
November 2017
17 Reads

CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies.

Hum Gene Ther 2017 12;28(12):1147-1157

1 Center for Molecular Medicine Cologne (CMMC), University of Cologne, and Deparment I for Internal Medicine, University Hospital Cologne , Cologne, Germany.

The treatment of leukemia/lymphoma by chimeric antigen receptor (CAR) redirected T cells with specificity for CD19 induced complete remissions in the majority of patients, with a realistic hope for cure. However, recent follow-up data revealed a substantial risk of relapse through leukemic cells that lack the CAR targeted antigen. In this situation, a bispecific CAR with binding domains for CD19 and CD20 is aimed at recognizing leukemic cells with only one cognate antigen. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2017.126DOI Listing
December 2017
9 Reads

Composite lymphomas: Experience from a tertiary cancer center in Kerala, South India.

Indian J Cancer 2017 Jan-Mar;54(1):358-361

Division of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Objectives: Composite tumors are defined as tumors in which there are two different intermixed histologic types. Our objective was to study the clinical and pathologic features of five cases of composite lymphoma.

Materials And Methods: Our study included five patients of composite lymphoma diagnosed over a period of 5 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijc.IJC_89_17DOI Listing
July 2018
5 Reads

PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.

Semin Nucl Med 2018 01 6;48(1):37-49. Epub 2017 Nov 6.

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA; Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address:

FDG-PET/CT is an established first-line diagnostic imaging tool used in the staging of most lymphomas and for post-therapy response assessment in Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL). Many of the subtypes of lymphoid neoplasms classified by the World Health Organization demonstrate significant FDG-avidity or uptake; however, many guidelines and Lugano classification do not recommend the use of FDG-PET/CT in assessing response to therapy for these non-HL, non-DLBCL subtypes as a first-line diagnostic tool. This article reviews the role of FDG-PET/CT in the evaluation of the other most common "FDG-avid" lymphomas than HL and DLBCL, the role of FDG-PET/CT before autologous stem cell transplant, and for post-treatment follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2017.09.004DOI Listing
January 2018
13 Reads